Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron - Gralla, R; Lichinitser, M; Van der Vegt, S; Sleeboom, H; Mezger, J; Peschel, C; Tonini, G; Labianca, R; Macciocchi, A; Aapro, M (Annals of Oncology, 2003)